ACCESS Newswire

ChemPartner

22.12.2023 22:02:41 CET | ACCESS Newswire | Press release

Share
ChemPartner Unveils Highly Anticipated Biology Database

Newly-launched database offers easier access to diverse tumor models and unveils the path to pharmaceutical breakthroughs

SHANGHAI, CHINA / ACCESSWIRE / December 22, 2023 / ChemPartner, a global leader in drug discovery and development services, today announced the launch of its long-awaited Biology Database. This innovative platform serves as a centralized hub, empowering ChemPartner's clientele with seamless access to a wealth of information on the organization's cutting-edge preclinical platforms. The database includes 800+ tumor models, 30+ cancer types, 20,000 genes, 2,300+ pathways, 1,800 SoC data from literature (500 internal), and 30+ analytic modules.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
ChemPartner Biology Database
Screenshot of the online Biology Database from ChemPartner

ChemPartner's renowned biology and pharmacology department, known for its vanguard oncology, immunology, CNS, and metabolic services, has curated an extensive collection of in vitro and in vivo models. The database boasts over 2,000 biochemistry assays, 800 cell lines, 500 patient-derived xenograft (PDX) models, 350 cell-derived xenograft (CDX) models, and 50 syngeneic models. Each model is meticulously characterized with comprehensive data encompassing genomics, pharmacology, histopathology, and relevant clinical information.

Cell Line Models - ChemPartner Biology Database

To ensure a smooth and efficient rollout of this substantial volume of data, the database will be introduced in stages. We are delighted to announce that the first stage, featuring cell line data, is now live on https://database.chempartner.com. Subsequent stages will include CDX, syngeneic, and PDX models, followed by biochemistry data.

The Biology Database, a flagship online collaborative platform, prominently features the Tumor Model Database. This revolutionary resource offers an array of features, including:

  • Unified Data Hub: Integration of dispersed tumor model data into a centralized database for efficient management and retrieval, simplifying user access to diverse tumor models.
  • Detailed Annotations: Each model is accompanied by intricate annotations including genomics, pathology, and pharmacology data, enabling rapid understanding of model characteristics and suitability for specific research needs.
  • Rapid Search and Filtering: Multidimensional search and filtering capabilities empower researchers to swiftly locate models based on cancer type, genomic features, drug sensitivity, and more.
  • Data Analysis and Mining: Robust tools facilitate tasks like drug mechanism analysis and biomarker discovery through differential gene expression and drug sensitivity analyses, supporting informed research decisions.
  • Data Visualization: Intuitive charts, statistics, and visualization tools present complex data clearly and concisely, aiding in model selection and analysis.

Dr. Lilly Xu, President of Shanghai ChemPartner, expressed enthusiasm about the launch saying, "We are excited to provide our customers with access to this powerful new resource. This comprehensive database will make it easier for our customers to find and use the right models for their research, propelling drug development towards new heights with better precision, efficacy, and efficiency."

-

About ChemPartner

ChemPartner is a leading global CRO and CDMO providing drug discovery, development, and manufacturing services to the pharmaceutical and biotechnology industries. With a team of over 2,000 scientists across multiple countries, ChemPartner offers a comprehensive range of services including preclinical pharmacology, toxicology, drug metabolism and pharmacokinetics, chemistry development, and biologics development. For more information, please visit https://chempartner.com and connect with ChemPartner on LinkedIn, X,  and YouTube.

Contact Information

Sarah Stapleton
Marketing Director
news@chempartner.com
6504199974

Related Images

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
ChemPartner Biology Database
Screenshot of the online Biology Database from ChemPartner
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Cell Line Models
Pie chart of cell line models available on the Biology Database from ChemPartner

SOURCE: ChemPartner

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Freedom Holding Corp. Founder Timur Turlov Announces Candidacy for FIDE Deputy President29.6.2026 15:25:00 CEST | Press release

ALMATY, KAZAKHSTAN AND NEW YORK, NY / ACCESS Newswire / June 29, 2026 / Timur Turlov, President of the Kazakhstan Chess Federation and founder and majority shareholder of Freedom Holding Corp., has announced his candidacy for the position of Deputy President of the International Chess Federation (FIDE). According to Turlov, his decision to run reflects the work the Kazakhstan Chess Federation has undertaken in recent years to develop, digitize and popularize chess across the country. "My goal is to bring more stability, balance and mutual understanding to FIDE. Freedom Holding Corp., as one of Central Asia's leading fintech groups, can help the federation become more digital and technology-driven," said Timur Turlov. He added that his candidacy also reflects Kazakhstan's growing role in the international chess community. "In this sense, I represent not only myself, but also Kazakhstan - a country that is increasingly seen internationally as a reliable partner, capable of building calm

Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting27.6.2026 01:40:00 CEST | Press release

TORONTO, ON / ACCESS Newswire / June 26, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company"), is pleased to announce that all six director nominees proposed by management were elected as directors of the Company at its annual meeting of shareholders held via live video webcast today. Each director will hold office until the close of the next annual meeting of the Company's shareholders or until their successors are duly elected or appointed. The following are the voting results based on proxies received and a vote by online ballot: Director Number of Votes Percentage of Votes Votes For: Votes Withheld: Votes For: Votes Withheld: Jaime Guillen 9,351,125 220,821 97.69% 2.31% James V. Lawless 9,345,405 226,541 97.63% 2.37% Marc Murnaghan 9,355,472 216,474 97.74% 2.26% Marcela Paredes de Vásquez 9,383,074 188,872 98.03% 1.97% Catherine Fagnan 9,386,661 185,285 98.06% 1.94% Adarsh P. Mehta 9,394,433 177,513 98.15% 1.85% About Polaris Renewable Energy Inc. Polaris Ren

FINOS Announces Intent to Form OSERA, a Global Financial Services-Led Alliance for Open Source Supply-Chain Resiliency in the Era of AI26.6.2026 15:00:00 CEST | Press release

Spearheaded by Moderne and Piloted by FINOS Institutional Members, the Open Source Enterprise Resiliency Alliance Mutualizes Open Source 'Backpatching', Promotes Vendor-Neutral Industry-Wide Remediation Standards and Accelerates Evidence-Based, Compliant Open Source Consumption at Scale NEW YORK CITY, NY / ACCESS Newswire / June 26, 2026 / At the Open Source in Finance Forum, FINOS, the financial services arm of the Linux Foundation, announced its intent to form an Open Source Enterprise Resiliency Alliance (OSERA), a global, vendor-neutral, member-governed coalition to strengthen the industry's supply chain resiliency. OSERA will strengthen the open source components that underpin the sector by securing them through a vendor-neutral, upstream-aware approach and accelerating their compliant consumption at scale. The announcement follows a successful Member-only end-to-end pilot phase by Deutsche Bank, Goldman Sachs, Morgan Stanley, Royal Bank of Canada (RBC), and TD Bank Group, in whic

Hydrosat and Kazakhstan Gharysh Sapary Sign Agreement to Advance Satellite-Based Water Intelligence Across Kazakhstan and Central Asia25.6.2026 17:00:00 CEST | Press release

BRUSSELS, BE / ACCESS Newswire / June 25, 2026 / Hydrosat, the leading provider of thermal infrared satellite data and AI-powered analytics, and JSC "NC "Kazakhstan Gharysh Sapary" (JSC "NC "KGS"), Kazakhstan's national space company, announced the signing of a Joint Activity Agreement during a ceremony held in Brussels on 23 June 2026. The agreement establishes the framework for a national-scale program to digitize water resources management using satellite-based thermal analytics and AI, with the potential to expand across Central Asia. The agreement was signed as part of the state visit of the Head of State of the Republic of Kazakhstan to Belgium. During the visit, a number of strategic agreements were concluded to advance artificial intelligence, science, digital infrastructure, and space technologies, creating new opportunities for investment, joint research, technology deployment, and international cooperation. Representing Kazakhstan at the signing ceremonies were Deputy Prime

GA-ASI Adapts Ground Control Station to Fly MQ-9B25.6.2026 16:00:00 CEST | Press release

World Leader in UAS Invests in Upgrades That Ease MQ-9B Procurement SAN DIEGO, CA / ACCESS Newswire / June 25, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is working to adapt its Block 30 Ground Control Stations (GCS) to fly the company's newer model MQ-9B SkyGuardian® and SeaGuardian® Remotely Piloted Aircraft. When these upgrades are complete, they will enable current users of the Block 30 system, originally designed to fly the MQ-9A Reaper®, to keep that equipment and use it to operate the more capable aircraft. Current users include the U.S. Air Force, U.S. Marine Corps, the Italian Air Force, the French Air Force, the United Arab Emirates Armed Forces, the Spanish Air Force, and the Royal Netherlands Air Force. GA-ASI developed the MQ-9B through its own internal research and development. The upgraded new aircraft required a new and more powerful GCS. The ongoing work with the Block 30 GCS now means that prospective users with existing stocks of equipment wouldn't ne

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye